TAF + Emtricitabine + Darunavir + Cobicistat Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Darunavir- 800 mg + Cobicistat-1 50 mg + Emtricitabine- 200 mg + TAF-10 mg
Reference Brands: Symtuza(Eu & US)
Category: Anti Viral
Darunavir, cobicistat, emtricitabine and tenofovir alafenamide (800/150/200/10 mg) single-tablet HIV-1 regimen. For importers, distributors, HIV clinics and hospital pharmacies needing a once-daily boosted protease inhibitor combination.
Manufacture or export TAF + Emtricitabine + Darunavir + Cobicistat? List it or send an offer →
Product Description:
This tablet joins a boosted protease inhibitor and a nucleoside backbone as one complete daily regimen for HIV-1. Darunavir 800 mg blocks the viral protease, so new virus particles cannot mature. Cobicistat 150 mg, a CYP3A inhibitor without antiviral action, boosts darunavir enough for once-daily dosing. Emtricitabine 200 mg and tenofovir alafenamide 10 mg block reverse transcriptase. Boosted darunavir has a high genetic barrier to resistance. The pack data print cobicistat as 1 50 mg; the correct figure is 150 mg.
It is used in adults and adolescents from 12 years weighing at least 40 kg, to start treatment or to switch while virologically suppressed, where no darunavir resistance is known. It is taken once daily with food. Darunavir contains a sulphonamide group, so caution is needed in sulphonamide allergy, and severe skin reactions and hepatitis are labelled risks. As with other cobicistat products the interaction list is wide. Stopping can trigger a hepatitis B flare in co-infected patients. Cobicistat-boosted darunavir is not recommended in pregnancy because exposure falls.
Sourcing notes. The tablet is prescription-only and registered nationally, and many markets still hold patent or data protection on it, so check the legal position before a generic filing. Generic dossiers need bioequivalence data for all four actives. Supply comes in HDPE bottles with a desiccant; tablets stay in the original bottle, tightly closed, at room temperature. Ask for the batch CoA, GMP certificate and CoPP, with stability covering zone IVb. Give bottle count, label languages and the age and weight wording you need in the leaflet.
TAF + Emtricitabine + Darunavir + Cobicistat — third party manufacturing & bulk supply
TAF + Emtricitabine + Darunavir + Cobicistat is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
TAF + Emtricitabine + Darunavir + Cobicistat is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of TAF + Emtricitabine + Darunavir + Cobicistat listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for TAF + Emtricitabine + Darunavir + Cobici... →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
This combination is used for the treatment of HIV-1 infection. It works by suppressing viral replication, increasing CD4 cell counts, and helping achieve long-term viral suppression when used as part of antiretroviral therapy.
It is made from the active ingredients tenofovir alafenamide (TAF), emtricitabine, darunavir, and cobicistat. TAF and emtricitabine are nucleoside reverse transcriptase inhibitors, darunavir is a protease inhibitor, and cobicistat is a pharmacokinetic enhancer.
A known trade name for this four-drug fixed combination is Symtuza in the USA, EU, and UK.
Symtuza is manufactured by Janssen (Johnson & Johnson) in collaboration with Gilead Sciences.
The generic name is tenofovir alafenamide + emtricitabine + darunavir + cobicistat.
The main brand name is Symtuza.
It is manufactured by Janssen in the EU/USA, with production also handled through their authorized global manufacturing partners.
Related Products
Tenofovir AF + Emtricitabine + Bictegravir
Strength:
Bictegravir-50 mg + Emtricitabine-200 mg + TAF-25 mg
Form: Tablet
Reference Brands: Biktarvy(EU & US)
View DetailsTAF + Emtricitabine + Rilpivirine
Strength:
(TAF) – 25 mg + Emtricitabine – 200 mg + Rilpivirine – 25 mg
Form: Tablet
Reference Brands: Odefsey(US & EU)
View DetailsGlecaprevir + Pibrentasvir
Strength:
Glecaprevir- 100 mg + Pibrentasvir - 40 mg
Form: Tablet
Reference Brands: Mavyret (US); Maviret (EU)
View DetailsTAF + Emtricitabine + Elvitegravir + Cobicistat
Strength:
Elvitegravir – 150 mg + Cobicistat – 150 mg + Emtricitabine – 200 mg + TAF – 10 mg
Form: Tablet
Reference Brands: Genvoya(US & EU)
View DetailsLenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View DetailsBrincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit